Orexigen: Anti-Obesity Drug Attempting to Enter Multiple Markets

Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.

Read more »

OneMedPlace announces program for the Seventh Annual OneMedForum: Investing in Healthcare 2014, Jan. 13-15

OneMedPlace announces program for the Seventh Annual OneMedForum: Investing in Healthcare 2014, Jan. 13-15

Read more »

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean […]

Read more »

“Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities Exchange “Postponed”; Amarantus BioScience (AMBS) DTC Chill Lifted. What is the Next Step for Corporate Governance in the Biotechnology Sector?

Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth.  Two […]

Read more »

“SEC’s A Crowd” SEC Finally Issues Determination on Internet-Based Crowdfunding Platforms. How Will This Affect Fundraising?

One of the major obstacles of growth for Internet based Crowdfunding platforms in the U.S. has been the reaction of […]

Read more »

Test Post

Read more »

Editor’s Note, October 24, 2013

Dear Subscriber, In the coming weeks we will be providing short profiles of selected companies presenting at the 7th Annual […]

Read more »

ISTO’s Cell Therapies Can Revolutionize Treatment of Joint, Bone Injuries

ISTO Technologies, Inc.is both a regenerative medicine and orthopedics company developing innovative cartilage and bone regeneration products for spinal therapy, sports medicine and trauma. ISTO is currently focused on the development of cell-based cartilage platform technology that can be applied to repair and regenerate damaged cartilage in the knee and spinal disc.

Read more »

Aridis Pharmaceuticals: Better Alternative to Traditional Antibiotics?

Aridis Pharmaceuticals is a private biotechnology company focusing on improved alternatives to traditional antibiotics for the treatment of pneumonia and Cystic Fibrosis in addition to a few other conditions.

Read more »

“Regulatory Rush”-The SEC Lifts The Ban On General Solicitation

On July 10th, 2013 new changes to regulations regarding the general solicitation of securities was announced by the Securities and […]

Read more »